全球过敏研究中的不平等贡献:对高收入,低收入和中等收入国家的比较研究
Andrés Noyola-Pérez1, Sandra Nora Gonzalez-Diaz1, Carlos Macouzet-Sanchez1
1Universidad Autónoma de Nuevo León, University Hospital "Dr. José Eleuterio González" Regional Center of Allergy and Clinical Immunology, Gonzalitos y Madero s/n Colonia Mitras Centro, Monterrey, Nuevo León, CP 64460, Mexico.
The World Allergy Organization journal
|November 10, 2025
概括
全球研究不平等性限制了低收入和中等收入国家 (LMICs) 在过敏学方面的贡献. 高额的文章处理费用和编辑委员会中的代表人数不足,为LMICs创造了重大障碍,阻碍了各种科学进步.
科学领域:
- 过敏和免疫学研究研究
- 全球卫生公平性全球卫生公平性
- 科学出版业的科学出版.
背景情况:
- 全球科学研究分布不均,有利于高收入国家 (HICs).
- 这种差异特别影响过敏学,限制了各种观点和解决过敏疾病的进展,这些过敏疾病不成比例地影响着服务不足的人群.
研究的目的:
- 分析过敏学领域科学研究贡献的全球差异.
- 确定低收入和中等收入国家 (LMICs) 在过敏研究出版和代表性方面面临的障碍.
主要方法:
- 来自2024年期刊引用报告的41个过敏学期刊的分析.
- 收集关于出版量,引用影响,文章处理费用 (APC) 和编辑委员会代表性的数据.
- 根据世界银行排名将国家分类为HIC或LMIC;采用了比较统计分析.
主要成果:
- 低收入和中等收入国家 (LMICs) 的贡献仅为18.6%的出版物,而HICs的贡献为85%.
- 期刊的中位数为8个HIC贡献者,而LMIC贡献者为2个.
- 高中等APC (3090美元) 和编辑委员会与HIC的地理位置对齐,为LMIC参与带来了重大障碍.
结论:
- 系统性障碍,包括高APC和有限的编辑委员会代表,限制LMIC在全球过敏学方面的贡献.
- 减少财务障碍,加强能力建设,确保公平的编辑代表是解决这些差异的关键.
- 包容性研究生态系统对于改善全球知识和对受过敏疾病影响的人群的结果至关重要.
相关概念视频
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Confounding in Epidemiological Studies
565
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
565
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Reactions
31.9K
Overview
31.9K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K


